Results 61 to 70 of about 646,053 (288)
Methods to assess the impact of mass oral cholera vaccination campaigns under real field conditions. [PDF]
PLoS ONE, 2014 There is increasing interest to use oral cholera vaccination as an additional strategy to water and sanitation interventions against endemic and epidemic cholera.
Jacqueline Deen +2 more
doaj +1 more source
Stockpiling oral cholera vaccine
Bulletin of the World Health Organization, 2012 Cholera is re-emerging as a threat on the global public health stage. The number of reported cases worldwide is back at the peak level observed two decades ago,1 new Vibrio cholerae strains have appeared and antimicrobial resistance has increased. Weak surveillance systems and the possibility of travel and trade sanctions contribute to widespread ...
William Perea +2 more
openaire +4 more sources
Post-licensure deployment of oral cholera vaccines: a systematic review
Bulletin of the World Health Organization, 2014 Objective To describe and analyse the characteristics of oral cholera vaccination campaigns; including location, target population, logistics, vaccine coverage and delivery costs.
Stephen Martin +13 more
semanticscholar +1 more source
mSphere, 2019 Vibrio cholerae infection provides long-lasting protective immunity, while oral, inactivated cholera vaccines (OCV) result in more-limited protection. To identify characteristics of the innate immune response that may distinguish natural V.
Ana A. Weil +13 more
doaj +1 more source
Cholera: An Overview with Reference to the Syrian Outbreak
Avicenna Journal of Medicine, 2023 Cholera is an acute type of diarrheal disease caused by intestinal infection with the toxin-producing bacteria Vibrio cholerae. The disease is still endemic in almost 69 countries, accounting for around 2.86 million cases and 95,000 deaths annually ...
Munawar Hraib +6 more
doaj +1 more source
Oral Vaccines Against Cholera [PDF]
Clinical Infectious Diseases, 2011 The current seventh pandemic of cholera, caused by serogroup O1, El Tor biotype, has now involved almost the entire developing world. The ongoing dynamic epidemiology of cholera, involving evolution of new strains, prolonged and more frequent epidemics, increased antimicrobial resistance, and awareness of the role of climate change upon the global ...
John D. Clemens +3 more
openaire +3 more sources
Progress in Surface Plasmon and Other Resonance Biosensors for Biomedical Applications
Advanced Materials Technologies, EarlyView.This is the shortened version: Recent advancements in surface plasmon resonance and other optical resonance biosensors for biomedical applications are presented. Advanced sensing strategies are examined for the detection of diverse analytes, integration of nanomaterials and machine learning, and emerging nonplasmonic modes like guided mode resonance ...
Faten Bashar Kamal Eddin +8 more
wiley +1 more source
, 2007 Vietnam currently produces an orally administered, bivalent (O1 and O139) killed whole-cell vaccine and is the only country in the world with endemic cholera to use an oral cholera vaccine in public health practice.
Anh, Dang Duc +13 more
core +1 more source
Recombinant expression systems: the obstacle to helminth vaccines? [PDF]
, 2007 A
Claerebout, Edwin +3 more
core +2 more sources
Russian vaccines against especially dangerous bacterial pathogens
Emerging Microbes and Infections, 2014 In response to the epidemiological situation, live attenuated or killed vaccines against anthrax, brucellosis, cholera, glanders, plague and tularemia were developed and used for immunization of at-risk populations in the Former Soviet Union.
Valentina A Feodorova +3 more
doaj +1 more source